updated 10/4/2010 9:16:27 AM ET 2010-10-04T13:16:27

ORANGEBURG, N.Y., Oct. 4, 2010 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI) ("Vision-Sciences") announced today that it has been awarded a Federal Supply Schedule ("FSS") Contract from the General Services Administration ("GSA") for its flexible endoscopy product lines. The contract period is from October 15, 2010 – October 14, 2015. This GSA contract enables access to the company's technology for all federal healthcare facilities, including the Veterans Administration, Indian Health Service, and Department of Defense facilities.

"We consider the GSA contract an important step for the company," stated Warren Bielke, Interim CEO. "We believe our technologies are uniquely suited to provide cost-effective, high performance flexible endoscopy solutions to our government clients in the VA Health Systems and other government healthcare facilities."

The GSA contract covers the Vision-Sciences 4000 and 5000 Series flexible endoscopy lines.
The 5000 Series line features advanced, digital, video-based endoscopes that contain the world's smallest diameter insertion tubes with a high resolution CCD camera at the tip of the scope, offering sharp, vibrant, full screen imaging. The 5000 Series video endoscopes also feature pioneering functional aspects, such as an integrated light emitting diode (LED) for illumination, and a compact, portable digital processing unit. The 4000 Series fiberscopes contain state-of-the-art fiber optic imaging, small diameter insertion tubes, and portability options, through the use of a battery-powered light source. Both lines utilize the company's pioneering EndoSheath® Technology, which combines flexible endoscopic technology with a sterile, disposable microbial barrier, providing healthcare facilities with a solution to meet the growing need for safe, efficient, and cost-effective flexible endoscopy.

Forward Looking Statements

Except for the historical information provided, the matters discussed in this release include forward-looking statements for the purposes of the safe harbor protections under The Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as Vision-Sciences or its management "believes," "expects," "allows," "anticipates," or other words or phrases of similar import.  Similarly, statements in this release that describe our business strategy, outlook, objectives, plans, intentions, or goals are also forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those in forward-looking statements.  Other risk factors are detailed in our most recent annual report and other filings with the Securities and Exchange Commission. We do not assume any obligation to update any forward-looking statements as a result of new information or future events or developments.

Vision-Sciences, Inc. designs, develops, manufactures and markets unique flexible endoscopic products utilizing sterile disposable sheaths, the Slide-On® EndoSheath® Technology, which provide the users quick, efficient product turnover while ensuring the patient a contaminant-free product.

Vision-Sciences owns the registered trademarks Vision Sciences®, Slide-On®, EndoSheath® and The Vision System®.  Information about Vision-Sciences' products is available at www.visionsciences.com.

The Vision-Sciences, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3876

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com